Medicare Enrolled
Dr. Andrew Germanovich, D.O., M.S.
Pain Medicine · Orange, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Germanovich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Germanovich?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Germanovich
Dr. Andrew Germanovich is a pain medicine specialist in Orange, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Germanovich performed 2,233 Medicare services across 923 unique beneficiaries.
Between the years covered by Open Payments, Dr. Germanovich received a total of $462,374 from 71 pharmaceutical and/or device companies across 804 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Germanovich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 25% volume in CA
$462,374 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,233
Medicare services
Top 25% in CA for pain medicine
923
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~131 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
683 | $0 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
500 | $106 | $550 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
341 | $75 | $390 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
87 | $83 | $1,169 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
63 | $109 | $1,292 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
48 | $106 | $1,115 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
47 | $60 | $565 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
45 | $48 | $560 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $135 | $713 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
38 | $82 | $346 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
30 | $49 | $267 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
30 | $52 | $257 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
29 | $225 | $2,885 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
29 | $47 | $235 |
| Injection, methylprednisolone acetate, 40 mg | 28 | $6 | $52 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
27 | $70 | $1,580 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
24 | $118 | $1,132 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
23 | $65 | $562 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
20 | $90 | $1,182 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
15 | $237 | $2,894 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
15 | $82 | $1,725 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
14 | $30 | $281 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
14 | $32 | $158 |
| X-ray of lower and sacral spine, minimum 6 views An X-ray imaging test that captures at least six views of the lower back and sacral spine to evaluate bone structure and alignment. |
13 | $57 | $272 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
13 | $35 | $187 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
13 | $23 | $535 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$462,374
Total received (2018-2024)
Avg $66,053/year across 7 years
Top 1% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
804
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$445,517 (96.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,399 (3.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,458 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,222
2023
$1,378
2022
$1,955
2021
$116,021
2020
$75,118
2019
$134,123
2018
$131,557
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Saluda Medical Americas, Inc.
$383
Boston Scientific Corporation
$306
BIOTRONIK NRO, Inc.
$266
Pacira Pharmaceuticals Incorporated
$258
IBSA Pharma Inc.
$195
Collegium Pharmaceutical, Inc.
$169
PFIZER INC.
$92
ABBVIE INC.
$79
Medtronic, Inc.
$76
TerSera Therapeutics LLC
$72
Abbott Laboratories
$67
Curonix LLC
$46
PAINTEQ LLC
$46
SCILEX PHARMACEUTICALS INC.
$37
Vertos Medical, Inc.
$36
Stryker Corporation
$22
Amgen Inc.
$22
Merz Pharmaceuticals, LLC
$20
Avanos Medical
$16
DJO, LLC
$16
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
Masimo Corporation
$445,257
Abbott Laboratories
$2,306
Nuvectra Corporation
$1,969
Biohaven Pharmaceuticals, Inc.
$1,458
Nevro Corp.
$729
Medtronic, Inc.
$649
Pacira Pharmaceuticals Incorporated
$546
ABBVIE INC.
$509
Amgen Inc.
$491
Lilly USA, LLC
$440
IBSA Pharma Inc.
$397
PFIZER INC.
$395
Saluda Medical Americas, Inc.
$383
Merz Pharmaceuticals, LLC
$362
Boston Scientific Corporation
$353
Collegium Pharmaceutical, Inc.
$341
TerSera Therapeutics LLC
$310
BIOTRONIK NRO, Inc.
$289
Biohaven Pharmaceutical Holding Company Ltd.
$285
Flowonix Medical Incorporated
$278
BOSTON SCIENTIFIC CORPORATION
$258
SPR Therapeutics, Inc
$252
SCILEX PHARMACEUTICALS INC.
$210
Allergan Inc.
$210
Curonix LLC
$197
Jazz Pharmaceuticals Inc.
$191
Radius Health, Inc.
$188
AbbVie Inc.
$181
Merz North America, Inc.
$165
Teva Pharmaceuticals USA, Inc.
$162
Flexion Therapeutics, Inc.
$160
Bioventus LLC
$153
Stryker Corporation
$148
RedHill Biopharma Inc.
$141
BioDelivery Sciences International, Inc.
$138
Forte Bio-Pharma LLC
$138
Foundation Fusion Solutions, LLC
$131
MERZ NORTH AMERICA, INC.
$122
Vericel Corporation
$101
Stimwave Technologies Incorporated
$96
Relievant Medsystems, Inc.
$92
Medtronic USA, Inc.
$88
Scilex Pharmaceuticals Inc.
$87
Allergan, Inc.
$84
Electronic Waveform Lab, Inc.
$82
PAINTEQ LLC
$79
FORTE BIO-PHARMA LLC
$77
Horizon Therapeutics plc
$73
DePuy Synthes Sales Inc.
$72
Novartis Pharmaceuticals Corporation
$56
Avanos Medical
$46
Vertos Medical, Inc.
$36
BioTissue Holdings, Inc.
$36
Daiichi Sankyo Inc.
$30
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$30
Ipsen Biopharmaceuticals, Inc
$30
Shionogi Inc
$29
Nalu Medical, Inc.
$29
ERMI Inc.
$28
Smith+Nephew, Inc.
$23
Zyla Life Sciences
$23
Vertical Pharmaceuticals, LLC
$21
Eisai Inc.
$19
FIDIA PHARMA USA INC.
$18
DJO, LLC
$16
Hikma Pharmaceuticals USA
$16
SANOFI-AVENTIS U.S. LLC
$15
TRICE MEDICAL, INC.
$14
Baudax Bio Inc.
$13
Assertio Therapeutics, Inc.
$11
Purdue Pharma L.P.
$11
Top 3 companies account for 97.2% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · Aimovig · Algovita · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BIOTRONIK · BOTOX · Belbuca · CAMBIA · COMIRNATY · DYSPORT · Dayvigo · Dysport · EMGALITY · EMMA and ISA · ETERNA · EXPAREL · Evoke · Exogen · Exogen Ultrasound Bone Healing System · Exparel · FORTEO · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · HYALGAN · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN RF · Intracept · Iovera · KRYSTEXXA · Kloxxado · LENS 4K · LICART · LORZONE · LYRICA · Licart · MACI · MILD DEVICE KIT · MONOVISC · Morphabond ER · Movantik · NEOX · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Octrode SCS Leads · Omnia · PAINTEQ · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCARE · PROCLAIM · PROLATE · Patient SafetyNet System · Penta SCS Leads · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Procure Biopsy Forceps · Prometra II · Prospera · QULIPTA · RESTORE · S-Series SCS Leads · SCS IPGs · SCS leads · SET and rainbow SET · SPATIAL FRAME · SPECTRA WAVEWRITER · SPINEJACK · SPRINT PNS System · STANDARD RF DISPOSABLES · SYMPROIC · SYNVISC-ONE · SedLine · Senza II · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Symproic · TRIVISC SODIUM HYALURONATE · Tirosint · Tymlos · UBRELVY · Vanta · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · Xeomin · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit · rainbow Acoustic Monitoring
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pain medicine in CA.
Geographic Context
Pain medicines within 10 mi
75
Per 100K population
2.4
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Germanovich is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Germanovich experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Germanovich performed 683 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Germanovich receive payments from pharmaceutical companies?
Yes. Dr. Germanovich received a total of $462,374 from 71 companies across 804 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Germanovich's costs compare to other pain medicines in Orange?
Dr. Germanovich's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Germanovich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Orange
Browse pain medicines in Orange ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
Masimo Corporation Payments to Doctors
See all physicians who received payments from Masimo Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Nuvectra Corporation Payments to Doctors
See all physicians who received payments from Nuvectra Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology